108 related articles for article (PubMed ID: 36127233)
1. Recurrence pattern in localized RCC: results from a European multicenter database (RECUR).
Fallara G; Larcher A; Dabestani S; Fossati N; Järvinen P; Nisen H; Gudmundsson E; Lam TB; Marconi L; Fernandéz-Pello S; Meijer RP; Volpe A; Beisland C; Klatte T; Stewart GD; Bensalah K; Ljungberg B; Bertini R; Montorsi F; Bex A; Capitanio U
Urol Oncol; 2022 Nov; 40(11):494.e11-494.e17. PubMed ID: 36127233
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Study of Controlling Nutritional Status (CONUT) Score as a Prognostic Factor in Patients With HIV-Related Renal Cell Carcinoma.
Xue W; Zhang Y; Wang H; Zhang Y; Hu X
Front Immunol; 2021; 12():778746. PubMed ID: 34917092
[TBL] [Abstract][Full Text] [Related]
3. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
[TBL] [Abstract][Full Text] [Related]
5. Recurrence Rates in Patients With Cervical Cancer Treated With Abdominal Versus Minimally Invasive Radical Hysterectomy: A Multi-Institutional Retrospective Review Study.
Uppal S; Gehrig PA; Peng K; Bixel KL; Matsuo K; Vetter MH; Davidson BA; Cisa MP; Lees BF; Brunette LL; Tucker K; Stuart Staley A; Gotlieb WH; Holloway RW; Essel KG; Holman LL; Goldfeld E; Olawaiye A; Rose SL
J Clin Oncol; 2020 Apr; 38(10):1030-1040. PubMed ID: 32031867
[TBL] [Abstract][Full Text] [Related]
6. Propensity-score matched oncological outcomes and patterns of recurrence following open and minimally-invasive partial nephrectomy for renal cell carcinoma.
Tam AW; Kutikov A; Winoker JS; Rosenzweig S; Waingankar N; Okhawere KE; Badani KK; Uzzo R; Mehrazin R
Urol Oncol; 2022 Mar; 40(3):111.e19-111.e25. PubMed ID: 35140050
[TBL] [Abstract][Full Text] [Related]
7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
9. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
10. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study.
Chen WK; Wu ZG; Xiao YB; Wang QQ; Yu DD; Cai J; Zhou CF
Technol Cancer Res Treat; 2021; 20():15330338211004914. PubMed ID: 33929915
[TBL] [Abstract][Full Text] [Related]
12. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
Bradshaw AW; Autorino R; Simone G; Yang B; Uzzo RG; Porpiglia F; Capitanio U; Porter J; Bertolo R; Minervini A; Lau C; Jacobsohn K; Ashrafi A; Eun D; Mottrie A; White WM; Schips L; Challacombe BJ; De Cobelli O; Mir CM; Veccia A; Larcher A; Kutikov A; Aron M; Dasgupta P; Montorsi F; Gill IS; Sundaram CP; Kaouk J; Derweesh IH
BJU Int; 2020 Jul; 126(1):114-123. PubMed ID: 32232920
[TBL] [Abstract][Full Text] [Related]
13. Survival after minimally invasive vs. open radical nephrectomy for stage I and II renal cell carcinoma.
Dursun F; Elshabrawy A; Wang H; Rodriguez R; Liss MA; Kaushik D; Gelfond J; Mansour AM
Int J Clin Oncol; 2022 Jun; 27(6):1068-1076. PubMed ID: 35319076
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.
Yu KJ; Keskin SK; Meissner MA; Petros FG; Wang X; Borregales LD; Gu C; Tamboli P; Matin SF; Wood CG; Karam JA
Cancer; 2018 Oct; 124(20):4023-4031. PubMed ID: 30276798
[TBL] [Abstract][Full Text] [Related]
15. Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer.
Segarra-Vidal B; Dinoi G; Zorrilla-Vaca A; Mariani A; Student V; Garcia NA; Llueca Abella A; Ramirez PT
Obstet Gynecol; 2021 Dec; 138(6):828-837. PubMed ID: 34735382
[TBL] [Abstract][Full Text] [Related]
16. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
17. SUCCOR study: an international European cohort observational study comparing minimally invasive surgery versus open abdominal radical hysterectomy in patients with stage IB1 cervical cancer.
Chiva L; Zanagnolo V; Querleu D; Martin-Calvo N; Arévalo-Serrano J; Căpîlna ME; Fagotti A; Kucukmetin A; Mom C; Chakalova G; Aliyev S; Malzoni M; Narducci F; Arencibia O; Raspagliesi F; Toptas T; Cibula D; Kaidarova D; Meydanli MM; Tavares M; Golub D; Perrone AM; Poka R; Tsolakidis D; Vujić G; Jedryka MA; Zusterzeel PLM; Beltman JJ; Goffin F; Haidopoulos D; Haller H; Jach R; Yezhova I; Berlev I; Bernardino M; Bharathan R; Lanner M; Maenpaa MM; Sukhin V; Feron JG; Fruscio R; Kukk K; Ponce J; Minguez JA; Vázquez-Vicente D; Castellanos T; Chacon E; Alcazar JL;
Int J Gynecol Cancer; 2020 Sep; 30(9):1269-1277. PubMed ID: 32788262
[TBL] [Abstract][Full Text] [Related]
18. Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82).
Tabourin T; Pinar U; Parra J; Vaessen C; Bensalah CK; Audenet F; Bigot P; Champy C; Olivier J; Bruyere F; Doumerc N; Paparel P; Parier B; Nouhaud FX; Durand X; Lang H; Branger N; Long JA; Durand M; Waeckel T; Charles T; Cussenot O; Xylinas E; Boissier R; Tambwe R; Patard JJ; Bernhard JC; Roupret M
Ann Surg Oncol; 2022 Oct; 29(11):7218-7228. PubMed ID: 35780452
[TBL] [Abstract][Full Text] [Related]
19. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
20. Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis.
Grassi P; Doucet L; Giglione P; Grünwald V; Melichar B; Galli L; De Giorgi U; Sabbatini R; Ortega C; Santoni M; Bamias A; Verzoni E; Derosa L; Studentova H; Pacifici M; Coppa J; Mazzaferro V; de Braud F; Porta C; Escudier B; Procopio G
PLoS One; 2016; 11(4):e0151662. PubMed ID: 27064898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
